Article
CD47 promotes mitogen-activated protein kinase and epithelial-to-mesenchymal transition molecular programs to drive prometastatic phenotypes in non-small cell lung cancer.
Molecular oncology - 1 Aug 2026
Lau Asa P Y, Zhai Lilian G, Hoshi Ryunosuke, Rousseau Zackary, Zakhary Abraam, Wu Yin Fang, Saleeb Rola M, Ni Heyu, Thu Kelsie L
Abstract excerpt
CD47 is best known for its role in tumor immune evasion; however, studies in diverse cell models indicate that it also has cell autonomous, tumor-promoting functions which are cell type- and context-specific. Motivated by the prognostic and therapeutic significance of CD47 and the limited knowledge regarding its roles beyond immune evasion in non-small cell lung cancer (NSCLC), we sought to define the cellular...
Topics
Join the communities discussing this publication.
